lercanidipine has been researched along with Stroke in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, TS; Huynh, VM; Tran, VH | 1 |
| Cheng, KC; Cheng, KH; Cheng, KY; Lai, WT; Lee, CW; Yang, YH | 1 |
| Harada, N; Niwa, M; Sakurai-Yamashita, Y | 1 |
1 trial(s) available for lercanidipine and Stroke
| Article | Year |
|---|---|
Effects of lercanidipine versus amlodipine in hypertensive patients with cerebral ischemic stroke.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Brain Ischemia; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged; Stroke; Treatment Outcome | 2015 |
3 other study(ies) available for lercanidipine and Stroke
| Article | Year |
|---|---|
Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study.
Topics: Adolescent; Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Cohort Studies; Dihydropyridines; Felodipine; Female; Humans; Hypertension; Male; Middle Aged; Retrospective Studies; Stroke; Taiwan; Young Adult | 2017 |
Lercanidipine rescues hippocampus pyramidal neurons from mild ischemia-induced delayed neuronal death in SHRSP.
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Cell Death; Dihydropyridines; Hippocampus; Ischemia; Neurons; Pyramidal Cells; Rats; Rats, Inbred SHR; Stroke | 2011 |
[ACE inhibitor and calcium antagonist in fixed combination: effective protection for hypertensive patients at risk].
Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Combined Modality Therapy; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hypertension; Physical Fitness; Stroke | 2012 |